1-Bromopropane


Curated chemical-disease associations from CTD
Disease IDDisease nameReference
MESH:D003072 Cognition Disorders PMID:23266320; PMID:23395825
MESH:D003866 Depressive Disorder PMID:23266320
MESH:D006470 Hemorrhage PMID:27421776
MESH:D006973 Hypertension PMID:27452781
MESH:D007246 Infertility PMID:17517825
MESH:D008569 Memory Disorders PMID:23266320
MESH:D009336 Necrosis PMID:20211940
MESH:D009461 Neurologic Manifestations PMID:21527306
MESH:D009845 Oligospermia PMID:17890766; PMID:19638432
MESH:D010243 Paralysis PMID:30247689
MESH:D013733 Testicular Diseases PMID:17890766
MESH:D015431 Weight Loss PMID:27452781
MESH:D019954 Neurobehavioral Manifestations PMID:30247689
MESH:D020233 Gait Disorders, Neurologic PMID:30247689
MESH:D020258 Neurotoxicity Syndromes PMID:17517825; PMID:27421776; PMID:30247689
MESH:D047508 Massive Hepatic Necrosis PMID:27421776
MESH:D053627 Asthenozoospermia PMID:19638432
MESH:D056486 Chemical and Drug Induced Liver Injury PMID:19638432; PMID:20211940; PMID:27421776
MESH:D064420 Drug-Related Side Effects and Adverse Reactions PMID:21527306

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.